Claims
- 1. A template-directed process for synthesizing polymers, the process comprising:
(a) providing a sequence-specific deoxyribonucleic acid (DNA) template having binding sites, the template further having a specific chain length; and (b) generating a sequence-specific polymer along the DNA template, the sequence-specific polymer having a chain length that corresponds to the specific chain length of the template, the sequence-specific polymer defining a sequence that complements the specific sequence defined by the DNA template, the generating of the sequence-specific polymer comprising:
(b1) providing modified nucleosides having the hydroxyl at the 5′-carbon replaced with an amine, the modified nucleosides further having the hydroxyl at the 3′-carbon replaced with an acetaldehyde; (b2) pre-arranging the modified nucleosides along the sequence-specific DNA template such that each of the modified nucleosides are bound to their respective complementary binding site on the DNA template; (b3) forming an imine between adjacent modified nucleosides by reacting the amine of one of the adjacent modified nucleosides with the acetaldehyde of the other of the adjacent modified nucleosides; and (b4) reducing the imine to form an amine between the adjacent modified nucleosides.
- 2. A template-directed process for synthesizing polymers, the process comprising:
replacing the hydroxyl at the 5′-carbon of a nucleoside with an amine; and replacing the hydroxyl at the 3′-carbon of the nucleoside with an acetaldehyde.
- 3. A template-directed process for synthesizing polymers, the process comprising:
providing a template having a specific chain length, the template defining a specific sequence; and generating a polymer along the template through a condensation reaction, the polymer having a chain length that corresponds to the specific chain length of the template, the polymer defining a sequence that corresponds to the specific sequence defined by the template.
- 4. The process of claim 3, wherein the template is a polynucleotide.
- 5. The process of claim 4, wherein the polynucleotide is a single strand of deoxyribonucleic acid (DNA),.
- 6. The process of claim 4, wherein the polynucleotide is a single strand of ribonucleic acid (RNA),
- 7. The process of claim 3, wherein the step of generating a polymer comprises:
providing modified nucleosides, the modified nucleosides having the hydroxyl at the 5′-carbon replaced with an amine, the modified nucleosides further having the hydroxyl at the 3′-carbon replaced with an acetaldehyde; arranging the modified nucleosides along the template; forming an imine between adjacent modified nucleosides along the template, the imine being formed by reacting the amine of one of the adjacent modified nucleosides with the acetaldehyde of the other of the adjacent modified nucleosides; and reducing the imine to form an amine between the adjacent nucleosides.
- 8. The process of claim 3, wherein the step of generating a polymer comprises:
polymerizing monomers along the template, the monomers having two reactive ends.
- 9. The process of claim 8, wherein the step of polymerizing monomers comprises:
providing monomers having an amine at one of the two reactive ends, the monomers further having an acetaldehyde at the other of the two reactive ends; arranging the monomers along the template such that each of the monomers binds to a complementary monomer on the template; forming an imine between adjacent monomers by reacting the amine of one of the adjacent monomers with the acetaldehyde of the other of the adjacent monomers; and reducing the imine to form an amine between the adjacent monomers.
- 10. The process of claim 3, wherein the step of generating a polymer comprises:
polymerizing oligomers along the template, the oligomers having two reactive ends.
- 11. The process of claim 10, wherein the step of polymerizing oligomers comprises:
providing oligomers having an amine at one of the two reactive ends, the oligomers further having an acetaldehyde at the other of the two reactive ends; arranging the oligomers along the template such that each monomer of each of the oligomers binds to a complementary monomer on the template; forming an imine between adjacent oligomers by reacting the amine of one of the adjacent oligomers with the acetaldehyde of the other of the adjacent oligomers; and reducing the imine to form an amine between the adjacent oligomers.
- 12. The process of claim 11, wherein the providing of the oligomers comprises:
providing an oligomer having an amide between adjacent monomers within the oligomer.
- 13. The process of claim 3, wherein the step of generating a polymer comprises:
polymerizing a combination of-an oligomer and a monomer along the template, the oligomer having two reactive ends, the monomer having two reactive ends.
- 14. The process of claim 13, wherein the step of polymerizing the combination of oligomers and monomers comprises:
providing a monomer having an amine at one of the two reactive ends, the monomer further having an acetaldehyde at the other of the two reactive ends; providing an oligomer having an amine at one of the two reactive ends, the oligomer further having an acetaldehyde at the other of the two reactive ends; arranging the monomer along the template such that the monomer binds to a complementary monomer on the template; arranging the oligomer along the template such that each monomer of the oligomer binds to a complementary monomer on the template; forming an imine by reacting one of the amines with one of the acetaldehydes and reducing the imine to-form an amine.
- 15. A nucleoside monomer comprising:
an amine at the 5′-carbon, the amine replacing a hydroxyl; and an acetaldehyde at the 3′-carbon, the acetaldehyde replacing a hydroxyl.
- 16. The nucleoside monomer of claim 15, wherein nucleoside monomer is selected from a group consisting of:
a synthetically-modified thymidine, the synthetically-modified thymidine being defined by 5′-H2N-dT-3′-CH2CHO; a synthetically-modified adenosine, the synthetically-modified adenosine being defined by 5′-H2N-dA-3′-CH2CHO; a synthetically-modified guanosine, the synthetically-modified guanosine being defined by 5′-H2N-dG-3′-CH2CHO; a synthetically-modified cytidine, the synthetically-modified cytidine being defined by 5′-H2N-dC-3′-CH2CHO; synthetically-modified uridine, the synthetically-modified uridine being defined by 5′-H2N-dU-3′-CH2CHO; and a synthetically-modified inosine, the synthetically-modified inosine being defined by 5′-H2N-dI-3′-CH2CHO.
- 17. A nucleoside oligomer comprising:
a first reactive end comprising a modified nucleoside having an amine chemically bonded to the 5′-carbon; and a second reactive end comprising a modified nucleoside having an acetaldehyde chemically bonded to the 3′-carbon.
- 18. The nucleoside oligomer of claim 17, wherein the modified nucleoside at the first reactive end is selected from a group consisting of:
a modified cytidine in which the 5′-OH is replaced with a 5′-N2H; a modified uridine in which the 5′-OH is replaced with a 5′-N2H; a modified adenosine in which the 5′-OH is replaced with a 5′-N2H; a modified inosine in which the 5′-OH is replaced with a 5′-N2H; a modified guanosine in which the 5′-OH is replaced with a 5′-N2H; and a modified thymidine in which the 5′-OH is replaced with a 5′-N2H.
- 19. The nucleoside oligomer of claim 17, wherein the modified nucleoside at the second reactive end is selected from a group consisting of:
a modified cytidine in which the 3′-OH is replaced with a 3′-CH2CHO; a modified uridine in which the 3′-OH is replaced with a 3′-CH2CHO; a modified adenosine in which the 3′-OH is replaced with a 3′-CH2CHO; a modified inosine in which the 3′-OH is replaced with a 3′-CH2CHO; a modified guanosine in which the 3′-OH is replaced with a 3′-CH2CHO; and a modified thymidine in which the 3′-OH is replaced with a 3′-CH2CHO.
- 20. A polymer comprising:
adjacent monomers; and a linker interposed between the adjacent monomers, the linker being selected from a group consisting of: an amine; and an amide.
- 21. The polymer of claim 20, wherein the monomers are modified nucleosides.
- 22. The polymer of claim 21, wherein the modified nucleosides are selected from a group consisting of:
a synthetically-modified thymidine, the synthetically-modified thymidine being defined by 5′-H2N-dT-3′-CH2CHO; a synthetically-modified adenosine, the synthetically-modified adenosine being defined by 5′-H2N-dA-3′-CH2CHO; a synthetically-modified guanosine, the synthetically-modified guanosine being defined by 5′-H2N-dG-3′-CH2CHO; a synthetically-modified cytidine, the synthetically-modified cytidine being defined by 5′-H2N-dC-3′-CH2CHO, synthetically-modified uridine, the synthetically-modified uridine being defined by 5′-H2N-dU-3′-CH2CHO; and a synthetically-modified inosine, the synthetically-modified inosine being defined by 5′-H2N-dI-3′-CH2CHO.
- 23. A polymer comprising:
adjacent monomers; and a linker interposed between the adjacent monomers, the linker being formed as a result of a condensation reaction.
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. provisional patent applications having serial No. 60/366,870, filed on Mar. 22, 2002, Ser. No. 60/420,533, filed on Oct. 23, 2002, and Express Mail mailing label number EV269328445US, filed on Mar. 21, 2003, which are incorporated herein by reference in their entireties.
Provisional Applications (3)
|
Number |
Date |
Country |
|
60366870 |
Mar 2002 |
US |
|
60420533 |
Oct 2002 |
US |
|
60456641 |
Mar 2003 |
US |